Home
>
National Drug Code (NDC)
>
Terazosin
Terazosin - 24236-669-20 - (Terazosin Hydrochloride)
Drug Information of Terazosin
| Product NDC: | 24236-669 |
| Proprietary Name: | Terazosin |
| Non Proprietary Name: | Terazosin Hydrochloride |
| Active Ingredient(s): | 2 mg/1 & nbsp; Terazosin Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Terazosin
| Product NDC: | 24236-669 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075317 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130328 |
Package Information of Terazosin
| Package NDC: | 24236-669-20 |
| Package Description: | 100 CAPSULE in 1 CANISTER (24236-669-20) |
NDC Information of Terazosin
| NDC Code | 24236-669-20 |
| Proprietary Name | Terazosin |
| Package Description | 100 CAPSULE in 1 CANISTER (24236-669-20) |
| Product NDC | 24236-669 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Terazosin Hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20130328 |
| Marketing Category Name | ANDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | TERAZOSIN HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
